Tech Company Financing Transactions

Advanced Biohealing Funding Round

On 2/27/2007, Advanced Biohealing raised $25.5 million in Series C financing from Safeguard Scientifics, Canaan Partners and Channel Medical Partners.

Transaction Overview

Announced On
2/27/2007
Transaction Type
Venture Equity
Amount
$25,500,000
Round
Series C
Proceeds Purpose
Proceeds from the financing will be used to execute the launch and expand the market for Dermagraft, approved by the U.S. Food and Drug Administration (FDA) as a treatment for full-thickness diabetic foot ulcers. Funding will also support the Company's clinical trials program, in-licensing activities and international expansion.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
36 Church Ln.
Westport, CT 06880
USA
Email Address
Overview
Advanced BioHealing (ABH) is a specialty biotechnology company focused on the development and marketing of cell-based and tissue-engineered products for wound care. We are a privately held company with two approved products: Dermagraft and TransCyte.
Profile
Advanced Biohealing LinkedIn Company Profile
Social Media
Advanced Biohealing Company Twitter Account
Company News
Advanced Biohealing News
Facebook
Advanced Biohealing on Facebook
YouTube
Advanced Biohealing on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Rakin
  Kevin Rakin LinkedIn Profile  Kevin Rakin Twitter Account  Kevin Rakin News  Kevin Rakin on Facebook
Chief Medical Officer
Jan Lessem
  Jan Lessem LinkedIn Profile  Jan Lessem Twitter Account  Jan Lessem News  Jan Lessem on Facebook
Chief Scientific Officer
Charles Hart
  Charles Hart LinkedIn Profile  Charles Hart Twitter Account  Charles Hart News  Charles Hart on Facebook
Controller
Marc Posel
  Marc Posel LinkedIn Profile  Marc Posel Twitter Account  Marc Posel News  Marc Posel on Facebook
Vice President
Therésa Dixon
  Therésa Dixon LinkedIn Profile  Therésa Dixon Twitter Account  Therésa Dixon News  Therésa Dixon on Facebook
Vice President
Dean Tozer
  Dean Tozer LinkedIn Profile  Dean Tozer Twitter Account  Dean Tozer News  Dean Tozer on Facebook
VP - Operations
Kathy McGee
  Kathy McGee LinkedIn Profile  Kathy McGee Twitter Account  Kathy McGee News  Kathy McGee on Facebook
VP - Sales
Keith O'Briant
  Keith O'Briant LinkedIn Profile  Keith O'Briant Twitter Account  Keith O'Briant News  Keith O'Briant on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/27/2007: BiPar Sciences venture capital transaction
Next: 2/27/2007: Spadac venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary